Rosen Law Files Class Action Against Unicycive Over FDA Disclosure Lapses
Image
New York – September 12, 2026 -- Rosen Law Firm has filed a securities class action against Unicycive Therapeutics, Inc. (NASDAQ: UNCY) covering purchasers of the company's securities between December 29, 2025 and June 29, 2026.
Lawsuit alleges Unicycive never audited its manufacturing vendor's facility
The complaint claims Unicycive had not inspected its third-party manufacturing vendor's plant or verified compliance with current good manufacturing practices, leaving the company without a reasonable basis to assert the vendor had fixed deficiencies previously cited by the U.S. Food and Drug Administration.